Glioblastoma-derived EVs enriched with FasL and CTLA-4 activate the NF-κB pathway in macrophages, which promotes M2 macrophage polarization to reshape an immunosuppressive TME [102]. This evidence concerns the gene CTLA4 and glioblastoma.